President & CEO of Synageva BioPharma Corp (
GEVA) Sanj K Patel sells 35,000 shares of GEVA on 12/03/2012 at an average price of $49.34 a share.
Synageva Biopharma Corp has a market cap of $1.19 billion; its shares were traded at around $49.47 with and P/S ratio of 564.2.
CEO Recent Trades:
- President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/03/2012 at the average price of 49.34. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 0.26% since.
- President & CEO Sanj K Patel sold 70,000 shares of GEVA stock on 09/04/2012 at the average price of 49.47. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has decreased by 0% since.
CFO Recent Trades:
- SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 10/16/2012 at the average price of 50.13. The price of the stock has decreased by 1.32% since.
- SVP, CFO Carsten Boess sold 6,618 shares of GEVA stock on 07/18/2012 at the average price of 48.82. The price of the stock has increased by 1.33% since.
Directors and Officers Recent Trades:
- Director, 10% Owner Julian Baker bought 886,000 shares of GEVA stock on 07/13/2012 at the average price of 41.2. Julian Baker owns at least 1,737,085 shares after this. The price of the stock has increased by 20.07% since.
- Director, 10% Owner Felix Baker bought 886,000 shares of GEVA stock on 07/13/2012 at the average price of 41.2. Felix Baker owns at least 1,736,565 shares after this. The price of the stock has increased by 20.07% since.
- Director Thomas J Tisch bought 73,000 shares of GEVA stock on 07/12/2012 at the average price of 41.2. Thomas J Tisch owns at least 730,956 shares after this. The price of the stock has increased by 20.07% since.
- Vice President, Finance Chris Heberlig sold 4,000 shares of GEVA stock on 10/17/2012 at the average price of 49.66. The price of the stock has decreased by 0.38% since.
- Vice President, Finance Chris Heberlig sold 1,000 shares of GEVA stock on 09/04/2012 at the average price of 49.1. The price of the stock has increased by 0.75% since.
For the complete insider trading history of GEVA,
click here.